the small pharmaceutical concern that developed the drug, LAB Pharmaceutical, lacked the resources to complete the lengthy approval process, manufacture the compound,and market the drug LAB had approached Merck with an offer to license the compound. under this agreement, Merck would be responsible for the approval of Davanrik, its manufacture, and its marketing.